3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
5
Leukemia, Myeloid, Acute
3
Leukemia
2
Waldenstrom Macroglobulinemia
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Leukemia, B-Cell
1
Dendritic Cell Sarcoma, Interdigitating
1
Interventions
Dexamethasone
16
daratumumab
9
Bortezomib
9
Lenalidomide
6
pomalidomide
4
carfilzomib
4
isatuximab
3
trametinib
2
selinexor
2
dabrafenib
2
Thalidomide
2
Prednisone
2
Melphalan
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
talquetamab
1
sapanisertib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
montelukast
1
melflufen
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
defactinib
1
darlin protein, Dictyostelium
1
copanlisib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Multiple Myeloma
×
venetoclax
×
Clear all
No trials found.